Literature DB >> 19540664

Anti-angiogenesis and anti-tumor effects of AdNT4-anginex.

Dan Feng Dong1, En Xiao Li, Ju Bo Wang, Yin Ying Wu, Fan Shi, Jun Jun Guo, Yuan Wu, Jun Ping Liu, Shan Xi Liu, Guang Xiao Yang.   

Abstract

Anginex is a novel artificial peptide that can inhibit angiogenesis. AdNT4-anginex was constructed by inserting the artificial anginex gene into a recombinant adenoviral vector. We demonstrated that AdNT4-anginex inhibited migration of human endothelial cells, angiogenesis and tumor growth in in vitro and in vivo studies. Tumor growth of human H22 hepatoma in mice was inhibited after AdNT4-anginex treatment for 4 weeks, and a significant decrease in tumor size was observed as compared with the control group. Overall, these studies indicate that AdNT4-anginex is an effective anti-tumor agent, and deserves more attention and research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540664     DOI: 10.1016/j.canlet.2009.05.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.

Authors:  Wei Zhu; Afu Fu; Jia Hu; Tianen Wang; Youfu Luo; Ming Peng; Yinghua Ma; Yuquan Wei; Lijuan Chen
Journal:  Exp Mol Med       Date:  2011-03-31       Impact factor: 8.718

2.  Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.

Authors:  Chen Lin; Menghua Wu; Jianyong Dong
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

Review 3.  Glycosylation in health and disease.

Authors:  Colin Reily; Tyler J Stewart; Matthew B Renfrow; Jan Novak
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 42.439

Review 4.  Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Authors:  Kamil Wdowiak; Tomasz Francuz; Enrique Gallego-Colon; Natalia Ruiz-Agamez; Marcin Kubeczko; Iga Grochoła; Jerzy Wojnar
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

5.  Antiangiogenic effects of AA-PMe on HUVECs in vitro and zebrafish in vivo.

Authors:  Yue Jing; Gang Wang; Qi Xiao; Yachun Zhou; Yingjie Wei; Zhunan Gong
Journal:  Onco Targets Ther       Date:  2018-04-04       Impact factor: 4.147

6.  Combination of anginex gene therapy and radiation decelerates the growth and pulmonary metastasis of human osteosarcoma xenografts.

Authors:  Kai Zhao; Shang-You Yang; Jun Geng; Xuan Gong; Weiming Gong; Lin Shen; Bin Ning
Journal:  Cancer Med       Date:  2018-04-16       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.